Hippotherapy Teenager-pediatric Radiotherapy

NCT06330142 | Recruiting

• 1 other identifier: 2022-006
• Study Type: interventional
• Target: 22
• Locations: 1 country
• Sites: 1

Brief Summary

This study proposes a horse-assisted therapy (HAT) approach to accompany children and young adults undergoing irradiation in the ICANS Radiotherapy Department. The aim of this new approach is to improve quality of life and reduce anxiety in children and adolescents treated with radiotherapy. The impact of equine-assisted therapy on quality of life and anxiety disorders will be described prospectively between the start and end of irradiation in children and parents who agree to inclusion.

Conditions

Radiotherapy

Keywords

Radiotherapy; Equicie; Adolescent; Pediatric

Outcome Measures

Primary Outcomes (1)

• Evolution of quality of life between the beginning and the end of horse-assisted therapy (HAT) in children (self-questionnaire) treated with radiotherapy

  The questionnaire used to assess quality of life will be completed by the child. Two versions of the VSP-A questionnaire exist, depending on the child's age (versions \< 10 years and 10-17 years). Results can be compared with reference values for the general population.

  before radiotherapy, halfway through the HAT sessions (at 5 weeks), at the end of the HAT sessions (at 10 weeks) and one month after the end of the HAT sessions

Secondary Outcomes (10)

• Improving children's quality of life between the start and end of irradiation (hetero-questionnaire) by HAT

  before radiotherapy, halfway through the HAT sessions (at 5 weeks), at the end of the HAT sessions (at 10 weeks) and one month after the end of the HAT sessions

• Decrease anxiety disorders between the beginning - child version and end of irradiation in children (self-questionnaire) with HAT

  before radiotherapy, halfway through HAT sessions (at 5 weeks), at the end of HAT sessions (at 10 weeks) and one month after the end of HAT sessions

• Decrease anxiety disorders between the beginning - parents' version and end of irradiation in children (self-questionnaire) with HAT

  before radiotherapy, halfway through HAT sessions (at 5 weeks), at the end of HAT sessions (at 10 weeks) and one month after the end of HAT sessions

• Assessing the acute side effects of radiotherapy at the start and end of irradiation

  at the start and end of radiotherapy sessions (from 3 to 7 weeks)

• Study the relevance of the various equestrian activities proposed as a strategy for improving care through the horse

  At every HAT sessions (up to 10 weeks)

Study Arms (1)

entire study population

OTHER

Other: Participation in 10 horse-assisted therapy sessions

Interventions

Participation in 10 horse-assisted therapy sessions OTHER

supporting children and teenagers undergoing radiotherapy with a horse-assisted therapy approach

entire study population

Eligibility Criteria

• Age: 8 Years - 17 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)

You may qualify if:

• Children aged 8 to \<18 years.
• With an indication for radiotherapy for cancer (of any type)
• Patients hospitalized and/or managed on an ambulatory basis
• WHO ≤ 2
• Child and parents (or accompanying adults) who speak and understand French
• Free, express and informed consent of the adult patient OR of those exercising parental authority for minor patients
• Child with social security coverage

You may not qualify if:

• Children afraid of horses and stables
• Contraindication to the practice of equine-assisted therapy (allergy to horses or dust, children with asthma attacks triggered by dust/animal hair ...)
• Patient on stretcher
• Children or parents (or carers) with significant cognitive impairment, making self-assessment or hetero-assessment impossible even with assistance
• Unavailability or lack of interest in participating in equine-assisted therapy sessions

Sponsors & Collaborators

• Centre Paul Strauss: lead

Study Sites (1)

Centre Paul Strauss

Strasbourg, 67033, France

RECRUITING

Central Study Contacts

Valérie SARTORI

CONTACT

368767223; v.sartori@icans.eu

Manon VOEGELIN

CONTACT

368767360; promotion-rc@icans.eu

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: OTHER
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 7, 2024
• First Posted: March 26, 2024
• Study Start: June 19, 2024
• Primary Completion (Estimated): June 19, 2027
• Study Completion (Estimated): June 19, 2027
• Last Updated: December 23, 2025

Record last verified: 2025-12

Locations

FR (1)